Results 131 to 140 of about 7,149 (178)

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort. [PDF]

Eur J Neurol
Samadzadeh S, Oertel FC, Salih H, Lin TY, Motamedi S, Chien C, Cook LJ, Lana-Peixoto MA, Fontenelle MA, Kim HJ, Hyun JW, Jung SK, Palace J, Roca-Fernandez A, Leite MI, Sharma SM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, Dcunha A, Aktas O, Ringelstein M, Albrecht P, May EF, Tongco C, Leocani L, Pisa M, Radaelli M, Sánchez-Dalmau B, Martinez-Lapiscina EH, Stiebel-Kalish H, Hellmann MA, Lotan I, Siritho S, de Seze J, Senger T, Havla J, Marignier R, Tilikete CF, Cobo-Calvo A, Bichuetti D, Tavares IM, Soelberg K, Altintas A, Yildirim R, Tanriverdi U, Jacob A, Huda S, Rimler Z, Reid A, Mao-Draayer Y, Villoslada P, de Castillo IS, Green A, Petzold A, Yeaman MR, Smith TJ, Brandt AU, Zimmermann HG, Paul F, Asgari N, Guthy Jackson Charitable Foundation – International Clinical Consortium and CROCTINO Collaborators.   +63 more
europepmc   +1 more source

Nocardia farcinica pneumonia complicated by pneumocystis jiroveci infection in children with Neuromyelitis Optica Spectrum Disorders: a case report and literature review. [PDF]

Ital J Pediatr
Liu L, Huang Y, Shu S, Zhou H, Fang F, Liu X.   +5 more
europepmc   +1 more source

Comparison of treatment efficacy and cost-effectiveness of rituximab and oral agents among patients with neuromyelitis optica spectrum disorders: a population-based cohort study. [PDF]

Ther Adv Neurol Disord
Lee HL, Kang M, Seok JM, Kim BJ, Kim BJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neuromyelitis optica spectrum disorders in Iran

Multiple Sclerosis and Related Disorders, 2017
Neuromyelitys optica spectrum disorder (NMOSD) is a rare demyelinating disease; as a result, the epidemiological data on this disorder is scarce. In this regard, the aim of this study was to estimate the prevalence, serology, and clinical features of NMOSD in Caucasian population in Tehran, Iran.A cross sectional study was performed in Tehran from 2015
Amirreza Azimi, Saharnaz Nedjat, Mohammad Ali Sahraian   +2 more
exaly   +3 more sources

Neuromyelitis optica and neuromyelitis optica spectrum disorders

Current Opinion in Neurology, 2017
Purpose of review The discovery of highly specific auto-antibodies directed against the water channel aquaporin 4 was a quantum leap in the definition, classification and management of neuromyelitis optica (NMO). Herein, we propose an update on epidemiological, clinical and therapeutic advances in the field, underlining unmet ...
Romain, Marignier, Alvaro, Cobo Calvo, Sandra, Vukusic   +2 more
openaire   +4 more sources

Epidemiology of neuromyelitis optica spectrum disorder

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021
Neuromyelitis optica spectrum disorder (NMOSD) is a group of rare and mostly severe autoimmune demyelinating central nervous system disorders which prevalence is 0.7-1 per 100.000 population and incidence is 0.037-0.73 per 100.000 person-years. NMOSD may present as a combination of uni- or bilateral optic neuritis, transverse myelitis or lesions of ...
M A, Sherman, A N, Boyko
openaire   +2 more sources

Neuromyelitis Optica Spectrum Disorder and Uveitis

Ocular Immunology and Inflammation, 2021
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare disease marked by CNS demyelination with a predilection for the optic nerve and spinal cord often resulting in severe vision loss. We aimed to characterize uveitis occurring in the setting of NMOSD.Retrospective chart review.Of 572 NMOSD patients, 1% were found to have uveitis with a relative ...
Andrew R, Carey, J Fernando, Arevalo
openaire   +2 more sources

Neuromyelitis Optica Spectrum Disorder

International Ophthalmology Clinics
Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune disease that predominantly affects the optic nerves and spinal cord, which is a distinct disease process from multiple sclerosis (MS) and myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease.
Negar Moheb, John J. Chen
  +6 more sources